A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come

por Ueland, Frederick R.
Publicado 2017

CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer

por Gorski, Justin W., Ueland, Frederick R., Kolesar, Jill M.
Publicado 2020

SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer

por Harbin, Laura M., Lin, Nan, Ueland, Frederick R., Kolesar, Jill M.
Publicado 2023

Salvaging Detection of Early-Stage Ovarian Malignancies When CA125 Is Not Informative

por Dunton, Charles J., Hutchcraft, Megan L., Bullock, Rowan G., Northrop, Lesley E., Ueland, Frederick R.
Publicado 2021

Characterization of Uterine Cervix Cancers in Women from Appalachian Kentucky

por Kunos, Charles A., Fabian, Denise, Kudrimoti, Mahesh, Miller, Rachel W., Ueland, Frederick R., Randall, Marcus E.
Publicado 2021

Human epidermal growth factor receptor 2 expression in women with uterine cervix adenocarcinoma from Appalachian Kentucky

por Kunos, Charles A., Fabian, Denise, Piecoro, Dava W., Napier, Dana, Miller, Rachel W., Ueland, Frederick R.
Publicado 2023

Hemoglobin level associates with survival in women from Appalachian Kentucky with uterine cervix cancer

por Kunos, Charles A., Fabian, Denise, Fredericks, Tricia, Baldwin, Lauren, Dietrich, Charles, Miller, Rachel W., Ueland, Frederick R.
Publicado 2023

Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells

por Burgess, Brian T., Anderson, Abigail M., McCorkle, J. Robert, Wu, Jianrong, Ueland, Frederick R., Kolesar, Jill M.
Publicado 2020

Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology Practice

por Rives, Taylor A., Pavlik, Heather, Li, Ning, Qasrawi, Lien, Yan, Donglin, Pickarski, Justine, Dietrich, Charles S., Miller, Rachel W., Ueland, Frederick R., Kolesar, Jill M.
Publicado 2023

DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden

por Riggs, McKayla J., Lin, Nan, Wang, Chi, Piecoro, Dava W., Miller, Rachel W., Hampton, Oliver A., Rao, Mahadev, Ueland, Frederick R., Kolesar, Jill M.
Publicado 2020

Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer

por McCorkle, J. Robert, Gorski, Justin W., Liu, Jinpeng, Riggs, McKayla B., McDowell, Anthony B., Lin, Nan, Wang, Chi, Ueland, Frederick R., Kolesar, Jill M.
Publicado 2021

Probability of Fallopian Tube and Ovarian Detection with Transvaginal Ultrasonography in Normal Women

por Lefringhouse, Jason R, Neward, Erin, Ueland, Frederick R, Baldwin, Lauren A, Miller, Rachel W, DeSimone, Christopher P, Kryscio, Richard J, van Nagell, John R, Pavlik, Edward J
Publicado 2016

Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance

por Gorski, Justin W., Zhang, Zhuwei, McCorkle, J. Robert, DeJohn, Jodi M., Wang, Chi, Miller, Rachel W., Gallion, Holly H., Dietrich, Charles S., Ueland, Frederick R., Kolesar, Jill M.
Publicado 2021

Complications from Surgeries Related to Ovarian Cancer Screening

por Baldwin, Lauren A., Pavlik, Edward J., Ueland, Emma, Brown, Hannah E., Ladd, Kelsey M., Huang, Bin, DeSimone, Christopher P., van Nagell, John R., Ueland, Frederick R., Miller, Rachel W.
Publicado 2017

Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes

por Hutchcraft, Megan L., Lin, Nan, Zhang, Shulin, Sears, Catherine, Zacholski, Kyle, Belcher, Elizabeth A., Durbin, Eric B., Villano, John L., Cavnar, Michael J., Arnold, Susanne M., Ueland, Frederick R., Kolesar, Jill M.
Publicado 2021

Symptoms Relevant to Surveillance for Ovarian Cancer

por Ore, Robert M., Baldwin, Lauren, Woolum, Dylan, Elliott, Erika, Wijers, Christiaan, Chen, Chieh-Yu, Miller, Rachel W., DeSimone, Christopher P., Ueland, Frederick R., Kryscio, Richard J., van Nagell, John R., Pavlik, Edward J.
Publicado 2017

Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery

por Smith, Christopher G., Davenport, Daniel L., Gorski, Justin, McDowell, Anthony, Burgess, Brian T., Fredericks, Tricia I., Baldwin, Lauren A., Miller, Rachel W., DeSimone, Christopher P., Dietrich, Charles S., Gallion, Holly H., Pavlik, Edward J., van Nagell, John R., Ueland, Frederick R.
Publicado 2019

Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies

por Wei, Ying, Erfani, Sonia, Schweer, David, de Gouvea, Rafael, Qadir, Javeria, Shi, Junfeng, Cheng, Kai, Wu, Dabao, Craven, Rolf, Wu, Yadi, Olivier, Thibault, Baldwin, Lauren A., Zhou, Binhua, Zhou, Ying, Zhao, Weidong, Yang, Burton B., Ueland, Frederick R., Yang, Xiuwei H.
Publicado 2023

Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers—Stage Challenges Categorical Assignments of Indolence & Aggressiveness

por Pavlik, Edward J., Smith, Christopher, Dennis, Taylor S., Harvey, Elizabeth, Huang, Bin, Chen, Quan, West Piecoro, Dava, Burgess, Brian T., McDowell, Anthony, Gorski, Justin, Baldwin, Lauren A., Miller, Rachel W., DeSimone, Christopher P., Dietrich, Charles, Gallion, Holly H., Ueland, Frederick R., van Nagell, John R.
Publicado 2020

Significance of Pelvic Fluid Observed during Ovarian Cancer Screening with Transvaginal Sonogram

por Gorski, Justin W., Dietrich, Charles S., Davis, Caeli, Erol, Lindsay, Dietrich, Hayley, Per, Nicholas J., Ferrell, Emily Lenk, McDowell, Anthony B., Riggs, McKayla J., Hutchcraft, Megan L., Baldwin-Branch, Lauren A., Miller, Rachel W., DeSimone, Christopher P., Gallion, Holly H., Ueland, Frederick R., van Nagell, John R., Pavlik, Edward J.
Publicado 2022